Rupali Jain
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 7
- Antifungal resistance and susceptibility 6
- Epidemiology 17
- Urinary Tract Infections Management 5
- Co-authors
- Larry H. Danziger (5 shared papers)Paul S. Pottinger (19 shared papers)Robert M. Rakita (7 shared papers)David N. Fredricks (3 shared papers)Ayesha Appa (1 shared paper)Helen Y. Chu (2 shared papers)Samuel L Aitken (4 shared papers)Shahin Hakimian (1 shared paper)
- Journals
- Open Forum Infectious Diseases (12 papers)Infection Control and Hospital Epidemiology (5 papers)Journal of the National Comprehensive Cancer Network (2 papers)Annals of Pharmacotherapy (2 papers)Journal of Cystic Fibrosis (2 papers)
- Partner nations
- United StatesSouth AfricaBelgium
In The Last Decade
Rupali Jain
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Molecular Medicine 306
- Applied Microbiology and Biotechnology 102
- Infectious Diseases 371
- Pharmacology 258
- Endocrinology 70
Countries citing papers authored by Rupali Jain
This map shows the geographic impact of Rupali Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupali Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupali Jain more than expected).
Fields of papers citing papers by Rupali Jain
This network shows the impact of papers produced by Rupali Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupali Jain. The network helps show where Rupali Jain may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupali Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 186 | |
| 2 | 2017 | 116 | |
| 3 | 2004 | 103 | |
| 4 | 2017 | 84 | |
| 5 | 2017 | 75 | |
| 6 | 2013 | 66 | |
| 7 | 2006 | 55 | |
| 8 | 2014 | 47 | |
| 9 | 2016 | 46 | |
| 10 | 2015 | 41 | |
| 11 | 2014 | 37 | |
| 12 | 2020 | 31 | |
| 13 | 2017 | 28 | |
| 14 | 2017 | 28 | |
| 15 | 2013 | 26 | |
| 16 | 2015 | 22 | |
| 17 | 2007 | 17 | |
| 18 | 2016 | 13 | |
| 19 | Electronic Surveillance For Catheter-Associated Urinary Tract Infection Using Natural Language Processing. | 2017 | 12 |
| 20 | 2019 | 12 |
About Rupali Jain
Rupali Jain is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Pharmacology and Oncology, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (14 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Bacterial Identification and Susceptibility Testing (10 papers), Neutropenia and Cancer Infections (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antifungal resistance and susceptibility (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Molecular Medicine (306 citations), Applied Microbiology and Biotechnology (102 citations), Infectious Diseases (371 citations), Pharmacology (258 citations) and Endocrinology (70 citations). Rupali Jain has collaborated with scholars based in United States, South Africa and Belgium. Frequent co-authors include Larry H. Danziger, Paul S. Pottinger, Robert M. Rakita, David N. Fredricks, Ayesha Appa, Helen Y. Chu, Samuel L Aitken, Shahin Hakimian, Jeannie D. Chan and Hu Xie. Their work appears in journals such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Journal of the National Comprehensive Cancer Network, Annals of Pharmacotherapy and Journal of Cystic Fibrosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.